Ion Channel Retreat (ICR2003)
Venue: Chateau Whistler Resort
|Event Date/Time: Jun 08, 2003||End Date/Time: Jun 11, 2003|
|Registration Date: Jun 08, 2003|
|Early Registration Date: Apr 30, 2003|
|Abstract Submission Date: Apr 30, 2003|
|Paper Submission Date: Apr 30, 2003|
Welcomes you to our Inaugural Ion Channel Retreat. The goal of this retreat is to:
facilitate communication between Ion Channel Scientists, especially users of Aurora Biomed's Screening Platforms,
allow attendees to hear how others are addressing the challenges and demands of their Ion Channel screening needs,
present new methods and techniques developed for application on the Aurora Biomed platforms
to provide the opportunity for attendees to see Aurora Biomed's new Automated Assay System and High Throughput ICR
Hear from leading academic and industrial experts like Merck, Aventis, AstraZeneca, Amgen, University of Washington, Johns Hopkins University and more on the latest advancements in ion channel research and bring back to your lab fresh insights for target screening and validation.
1. Channel Therapeutic Targets
2. Ion Channels and Drug Toxicity
3. HTS of Ion Channels for Drug Discovery and Toxicity : Case Studies and Applications
4. Cell-Based Efflux Assays for Analysis of Sodium, Potassium and Chloride Channels.
5. Emerging Technologies for Ion Channel Research.
William A. Catterall, PhD,
Professor and Chair, Department of Pharmacology
University of Washington
"Structure and Molecular Pharmacology of Sodium Ion Channels"
Georg C. Terstappen, PhD,
Vice president, Discovery Research
"Nonradioactive Rb Efflux Assay And Emerging Technologies In Ion Channel Drug Discovery"
Min Li, PhD,
Associate Professor, Department of Neuroscience
Johns Hopkins University, School of Medicine
"High throughput approaches to study potassium channels - innovations for the "unwanted" targets"
Head of Automated Screening, Drug Discovery
"Ion Channels: What HTS Needs